Overview

Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes

Status:
Unknown status
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Diabetes increases the risk of heart failure. This is mainly due to a disease of the blood vessels supplying the heart muscle and/or high blood pressure, but abnormal metabolism may also contribute. We plan to study the mechanisms involved in this abnormal metabolism, whilst also assessing the effects of a drug called Perhexiline which improves the abnormal metabolism that is present in diabetic patients before the development of heart failure.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University Hospital Birmingham
Collaborator:
British Heart Foundation
Treatments:
Perhexiline